Cystectomy for muscle-invasive bladder cancer: Patterns and outcomes of care in the medicare population

Urology

Volumn 65, Issue 6, 2005, Pages 1118-1125

  Schrag, Deborah ^a   Mitra, Nandita ^a   Xu, Feng ^a   Rabbani, Farhang ^a   Bach, Peter B ^a   Herr, Harry ^a   Begg, Colin B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MUSCLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DATA BASE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MEDICARE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 20444452924     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.12.029     Document Type: Article

References (32)

1. M.A. Dimopoulos, E. Galani Randomized trials of adjuvant and neoadjuvant chemotherapy in bladder cancer Semin Urol Oncol 19 2001 59 65
2. G. Dalbagni, E. Genega, M. Hashibe Cystectomy for bladder cancer a contemporary series J Urol 165 2001 1111 1116
3. National Comprehensive Cancer Network Bladder cancer, including upper tract tumors and transitional cell carcinoma of the prostate. National Comprehensive Cancer Network 2003 At http://www.nccn.org. Accessed August 1, 2004
4. H.W. Herr, W.U. Shipley, D.F. Bajorin Cancer of the bladder V.T. DeVita S.A. Rosenberg S. Hellman Cancer Principles and Practice of Oncology 2001 Lippincott Williams & Wilkins Philadelphia
5. Surveillance, Epidemiology, and End Results (SEER) Web site. 1999. At http://www-seer.ims.cci.nih.gov. Accessed December 27, 1999.
6. SEER Cancer Statistics Review, 1975-2000. National Cancer Institute. At http://seer.cancer.gov/csr/1975_2001/. Accessed August 1, 2004.
7. C. Percy, V. Van Holton, C.E. Muir International Classification of Diseases for Oncology 1990 World Health Organization Geneva
8. A.L. Potosky, G.F. Riley, J.D. Lubitz Potential for cancer related health services research using a linked Medicare-tumor registry database Med Care 31 1993 732 748
9. F.L. Greene, D.L. Page, I.D. Fleming AJCC Cancer Staging Manual 2002 Springer New York
10. International Classification of Diseases 2000 American Medical Association Publications Chicago 9th revision, ICD-9-CM
11. P.S. Romano, L.L. Roos, J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data differing perspectives J Clin Epidemiol 46 1993 1075 1079 discussion 1081-1090
12. M.E. Charlson, P. Pompei, K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies development and validation J Chronic Dis 40 1987 373 383
13. C.N. Klabunde, A.L. Potosky, J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
14. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
15. R.B. D'Agostino Issues of study design and data analysis Inflamm Bowel Dis 4 1998 109 113
16. W.G. Cochran The effectiveness of adjustment by subclassification in removing bias in observational studies Biometrics 24 1968 295 313
17. D.B. Rubin Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 1997 757 763
18. D.B. Rubin, N. Thomas Matching using estimated propensity scores relating theory to practice Biometrics 52 1996 249 264
19. P.R. Rosenbaum Discussing hidden bias in observational studies Ann Intern Med 115 1991 901 905
20. P.R. Rosenbaum, D.B. Rubin The bias due to incomplete matching Biometrics 41 1985 103 116
21. D.Y. Lin, B.M. Psaty, R.A. Kronmal Assessing the sensitivity of regression results to unmeasured confounders in observational studies Biometrics 54 1998 948 963
22. A.R. Feinstein, D.M. Sosin, C.K. Wells The Will Rogers phenomenon stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1985 1604 1608
23. Priorities of the Kidney/Bladder Cancers Progress Review Group. National Cancer Institute, 2002. At http://prg.nci.nih.gov/kidney/finalreport.html. Accessed September 27, 2004.
24. J.P. Stein Indications for early cystectomy Semin Urol Oncol 18 2000 289 295
25. D.S. Kaufman, W.U. Shipley, P.P. Griffin Selective bladder preservation by combination treatment of invasive bladder cancer N Engl J Med 329 1993 1377 1382
26. E.P. McCarthy, L.I. Iezzoni, R.B. Davis Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care 38 2000 868 876
27. S.S. Lloyd, J.P. Rissing Physician and coding errors in patient records JAMA 254 1985 1330 1336
28. D.C. Hsia, W.M. Krushat, A.B. Fagan Accuracy of diagnostic coding for Medicare patients under the prospective-payment system N Engl J Med 318 1988 352 355
29. L.I. Iezzoni The risks of risk adjustment JAMA 278 1997 1600 1607
30. American Cancer Society Cancer Facts and Figures 2002. At http://www.cancer.org/docroot/STT/stt_0.asp. Accessed August 1, 2004
31. L.F. Hutchins, J.M. Unger, J.J. Crowley Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 1999 2061 2067
32. H.B. Grossman, R.B. Natale, C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866